Approval · Notice of Compliance 34389 · 2024
NUVARING: Notice of Compliance 34389
Issued November 15, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 34389
- Date
- November 15, 2024
- Company
- Organon Canada Inc.Kirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the Product Monograph as per advisement letter
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NUVARING | Not yet assigned | — |
Medicinal ingredients
- ETHINYL ESTRADIOL 2.6 MG per RING
- ETONOGESTREL 11.4 MG per RING